Identification of C3a and N-truncated C3a as vascular permeability- enhancing factors from the exudate of chronic phase of carrageenan-induced inflammation in rats

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 5, 2002, Pages 648-651

  Miyama, Katsuyoshi ^a,b   Takano, Katsuhiko ^a   Atsumi, Ikuyo ^a   Nakagawa, Hideo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

C3a; Chronic inflammation; Exudate; Vascular permeability

Indexed keywords

ANAPHYLATOXIN; CARRAGEENAN; CYPROHEPTADINE; PLASMIN; COMPLEMENT COMPONENT C3A; HISTAMINE H1 RECEPTOR ANTAGONIST;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EXUDATE; INFLAMMATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PURIFICATION; RAT; ANIMAL; BLOOD FLOW; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MOLECULAR WEIGHT; PHYSIOLOGY; SKIN; VASCULARIZATION; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; CAPILLARY PERMEABILITY; CARRAGEENAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT C3A; CYPROHEPTADINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXUDATES AND TRANSUDATES; HISTAMINE H1 ANTAGONISTS; INFLAMMATION; MALE; MOLECULAR WEIGHT; PLASMIN; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SKIN;

EID: 0036583516     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.648     Document Type: Article

References (16)

1. Daffern P. J., Pfeifer P. H., Ember J. A., Hugli T. E., J. A., Med., 181, 2119-2127 (1995).
2. Nilsson G., Johnell M., Hammer C. H., Tiffany H. L., Nilsson K., Metcalfe D. D., Siegbahn A., Murphy P. M., J. Immunol., 157, 1693-1698 (1996).
3. Nakagawa H., Komorita N., Biochem. Biophys. Res. Commun., 194, 1181-1187 (1993).
4. Humbles A. A., Bao L., Nilsson C. A., Lilly C., Israel E., Fujiwara Y., Gerard N. P., Gerard C., Nature (London), 406, 998-1001 (2000).
5. Fukuhara M., Tsurufuji S., Biochem. Pharmacol., 18, 475-484 (1969).
6. Nakagawa H., Isaji M., Hayashi M., Tsurufuji S., J. Biochem. (Tokyo), 89, 1081-1090 (1981).
7. Schagger H., Von Jagow G., Anal. Biochem., 166, 368-379 (1987).
8. Udaka K., Takeuchi Y., Movat H. Z., Exp. Biol. Med., 133, 1384-1387 (1970).
9. Wallace J. L., Chapman K., McKnight W., Br. J. Pharmacol., 126, 1200-1204 (1999).
10. Sayar K., Melli M., Eur. J. Pharmacol., 369, 365-371 (1999).
11. Ueno A., Naraba H., Ikeda Y., Ushikubi F., Murata T., Narumiya S., Oh-ishi S., Life Sci., 66, PL155-PL160 (2000).
12. Kawamura M., Hatanaka K., Saito M., Ogino M., Ono T., Ogino K., Matsuo S., Harada Y., Eur. J. Pharmacol., 400, 127-135 (2000).
13. Hedqvist P., Gautam N., Lindbom L., Am. J. Respir. Crit. Care Med., 161, S117-S119 (2000).
14. Sala A., Folco G., Biochem. Biophys. Res. Commun., 283, 1003-1006 (2001).
15. Decarie A., Adam A., Coutune R., Peptides, 17, 1009-1015 (1996).
16. Majima M., Kawashima N., Hiroshi I., Katori M., Br. J. Pharmacol., 121, 723-730 (1997).